La vendita allo scoperto per Maximus dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Maximus. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Maximus (NYSE:MMS) Azioni, Report sulle vendite allo scoperto

Maximus

Maximus Inc is an operator of government health and human services programs in the United States, United Kingdom, Canada, Australia, and Saudi Arabia. The company offers business solutions to improve the cost-effectiveness, efficiency, and quality of government-sponsored benefit programs, such as Medicaid, Medicare, Health Insurance BC, and child support programmes. Most of its revenue is derived from long-term contractual arrangements with governments around the world. The company generates maximum revenue from the U.S. Federal Services segment.

Maximus Inc

IndexIQ Active ETF Trust IQ MacKay Multi-Sector Income ETF

MEGMILK SNOW BRAND CO LTD by MEGMILK SNOW BRAND CO LTD.

Megmilk Snow Brand Co Ltd

First Trust Multi-Manager Small Cap Opportunities ETF

MACARTHUR MINERALS LTD by Macarthur Minerals Ltd.

MCMILLAN SHAKESPEARE ADR by McMillan Shakespeare Ltd

McMillan Shakespeare Ltd

Merit Medical Systems, Inc. - Common Stock

Merit Medical Systems Inc

Macarthur Minerals Ltd

MITSU MNG&SMLTNG UNSP/ADR by Mitsu Mining & Smelting Co., Ltd.

Mitsui Mining and Smelting Co Ltd

Mirrored Microsoft

News

Maximus Secures Spot On $300M IRS Consulting Services Blanket Purchase Agreement, Enabling Strategic Planning And Business Process Improvement To Enhance Taxpayer Services Over A Five-Year Term

Maximus expands role under second EDOS task order delivering modernized services for the IRS Enterprise Data Platform (EDP)
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fmaximus.com&amp;esheet=54120626&amp;newsitemid=20240912135262&amp;lan=en-US&amp;anchor=Maximus&amp;index=1&amp;md5=34f38517397592c0a467ab7831594e6f">Maximus</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>), a leading employer and provider of government services worldwide, today announced it has been awarded a five-year, $40 million task order by the Internal Revenue Service (IRS) to deliver end-to-end development and modernization services for the IRS Enterprise Data Platform (EDP).
The IRS awarded Maximus the task order through the Blanket Purchase Agreement (BPA) for the Enterprise Development, Operations Services (EDOS) contract, which supports the agency's modernization plans for delivering world-class customer service to taxpayers. Previously, the IRS named Maximus to the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fmaximus.com%2Fnews%2Fmaximus-awarded-transformational-irs-enterprise-development-operations-service-edos-contract&amp;esheet=54120626&amp;newsitemid=20240912135262&amp;lan=en-US&amp;anchor=multiple-award+BPA+in+May+2023&amp;index=2&amp;md5=34f15849cc2830bbc785f89bae3050ac">multiple-award BPA in May 2023</a>. This is the second task order for Maximus through EDOS, having announced an <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestor.maximus.com%2Fnews-events%2Fpress-releases%2Fdetail%2F542%2Fmaximus-awarded-87-million-task-order-under-irs&amp;esheet=54120626&amp;newsitemid=20240912135262&amp;lan=en-US&amp;anchor=%2487+million+task+order+in+June&amp;index=3&amp;md5=66fb4a6914c142d01285ded6e515b6b4">$87 million task order in June</a> for modernization of the IRS Suite of Financial Systems.

Contracts

Maximus Awarded 5-Year $40M Task Order By The IRS To Deliver End-To-End Development And Modernization Services For The IRS Enterprise Data Platform

Maximus is Contact Center Services Provider for new program launching in November
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fmaximus.com&amp;esheet=54113478&amp;newsitemid=20240827600267&amp;lan=en-US&amp;anchor=Maximus&amp;index=1&amp;md5=368aa40e8098be2e69e4bebae1b2478c">Maximus</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>), a leading employer and provider of government services worldwide, today announced it has been awarded a $20 million contract from the Office of Personnel Management (OPM) to serve as the Contact Center Services Provider for the agency's new <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.opm.gov%2Fhealthcare-insurance%2Fpshb%2F&amp;esheet=54113478&amp;newsitemid=20240827600267&amp;lan=en-US&amp;anchor=Postal+Service+Health+Benefits+Program&amp;index=2&amp;md5=0931bc92c966a7e922bc73199a8fda18">Postal Service Health Benefits Program</a>. This program will provide health insurance to eligible Postal Service employees, annuitants, and their eligible family members starting in 2025.
Maximus will be leading the customer support effort to answer calls and emails for OPM's new, enhanced customer service platform dedicated to assisting eligible individuals access health insurance benefits. Maximus will leverage offerings from its Total Experience Management (TXM) solution, including state-of-the-art telephony, customer relationship management, and call quality reporting tools to provide best-in-class customer service.

Maximus Awarded A $20M Contract From The Office Of Personnel Management To Serve As The Contact Center Services Provider For The Agency's New Postal Service Health Benefits Program

Maximus's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) short percent of float has risen 9.64% since its last report. The company recently reported that it has 593 thousand shares sold short, which is 1.82% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.92 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Maximus Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1724081411_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Maximus has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Maximus's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Maximus's peer group average for short interest as a percentage of float is 4.88%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

How Is The Market Feeling About Maximus?

Further Raise to FY24 Guidance
Maximus is further raising fiscal year 2024 guidance following its third quarter results. Revenue is now expected to range between $5.25 billion and $5.35 billion, representing an increase of $100 million from the midpoint of prior guidance.
Adjusted operating income is now expected to range between $570 million and $590 million, representing an increase of $30 million from the midpoint of prior guidance. Adjusted operating income excludes an estimated $90 million of expense for amortization of intangible assets and $1 million of divestiture-related charges.
Adjusted diluted earnings per share is now expected to range between $6.00 and $6.20 per share, representing an increase of $0.35 per share from the midpoint of prior guidance.

Guidance

Maximus Sees FY24 Revenue $5.25B-$5.35B Vs $5.23B Estimate; Sees Adj. EPS $6.00-$6.20 Vs $4.73 Estimate

Maximus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) reported quarterly earnings of $1.74 per share which beat the analyst consensus estimate of $1.34 by 29.85 percent. The company reported quarterly sales of $1.315 billion which beat the analyst consensus estimate of $1.285 billion by 2.33 percent. This is a 10.60 percent increase over sales of $1.189 billion the same period last year.

Earnings

Earnings Beats

Maximus Q3 2024 Adj. EPS $1.74 Beats $1.34 Estimate, Sales $1.315B Beat $1.285B Estimate

Maximus, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mms#NYSE">MMS</a>) will report third-quarter fiscal 2024 results on Aug 7, after the bell.
The Zacks Consensus Estimate for earnings in the to-be-reported quarter stands at $1.47, indicating 88.5% growth from the year-ago reported quarter. The consensus estimate for revenues is pegged at $1.3 billion, indicating 7.4% year-over-year growth.
Earnings and revenues are expected to increase 51.2% and 6.8%, respectively, in fiscal 2024 and 2025. There has been no change in analyst estimates or revisions lately.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/e9/73382.jpg?v=469037917" style="height:310px; width:600px" />
Image Source: Zacks Investment Research
The company&#39;s earnings surprise history has not been impressive. Earnings missed the Zacks Consensus Estimate in two of the trailing four quarters and surpassed twice, with an average negative surprise of 2.7%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/e4/73383.jpg?v=102415083" style="height:310px; width:600px" />
Image Source: Zacks Investment Research
<h3>Lesser Chance of Q3 Earnings Beat</h3>
Our proven model doesn&#39;t conclusively predict an earnings beat for MMS this time around. The combination of a positive&nbsp;Earnings ESP&nbsp;and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that&#39;s not the case here.
MMS has an Earnings ESP of 0.00% and a Zacks Rank #3.
<h3>Strong Operations in the U.S. Should be the Driver in Q3</h3>
We expect that year-over-year improvement in the company&#39;s top line in the to-be-reported quarter will be driven by an increase in the U.S. Federal Services and U.S. Services segment&#39;s revenues, partially offset by weakness in Outside the U.S. segment.
The consensus estimate for the U.S. Federal Services revenues is pegged at $652.7 million, indicating 11.8% year-over-year growth. The consensus mark for the U.S. Services revenues is pegged at $475.9 million, indicating 6% year-over-year growth. The consensus mark for the Outside the U.S. Services revenuesis pegged at $147.8 million, indicating a 5% year-over-year decline.
MMS&#39; operating loss in the to-be-reported quarter is expected to be $2.93 million, a significant contraction from a loss of $24 million reported in the year-ago quarter.
<h3>The Stock is Rallying</h3>
MMS shares have surged 16.2% over the past six months. This performance has significantly outpaced the 5.6% rise of its industry and the 8.5% rally of the Zacks S&amp;P 500 composite. Among its close competitors, Booz Allen Hamilton (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bah#NYSE">BAH</a>) has gained 1.5% and Accenture (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/acn#NYSE">ACN</a>) has dipped 12.7% over the same period.
<h3>Six-Month Price Performance</h3>
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/a9/73384.jpg?v=376761409" style="height:315px; width:600px" />
Image Source: Zacks Investment Research
<h3>Investment Thoughts</h3>
With more than 40 years of experience, Maximus has become a leading global operator of government health and human services programs. Its expertise in business process management and ability to deliver cost-effective, efficient solutions make it a valuable partner for governments. Maximus has strong relationships and a solid reputation with governments, leading to predictable recurring revenue from long-term contracts. The company seeks long-term client relationships in existing and new markets and is expanding in clinical services and long-term services. Rising longevity and complex health needs boost demand for its services.
Maximus&#39; commitment to shareholder returns offers investors long-term wealth growth. The company paid cash dividends of around $68 million annually in recent fiscal years.
<h3>Wait for a Better Entry Point</h3>
MMS&#39; strong standing as a technology leader, facilitating the transformation of government programs to become dynamic and integrated, indicates significant long-term growth potential, but timing the market entry is crucial for maximizing investment returns.
While MMS remains fundamentally strong, a more advantageous entry point could emerge if the stock undergoes some correction that may begin soon, especially when MMS does not seem poised for an earnings beat this season.
<a href="https://www.zacks.com/stock/news/2316356/should-maximus-mms-stock-be-in-your-portfolio-pre-q3-earnings?cid=CS-BENZ-FT-analyst_blog|most_popular_stocks-2316356">To read this article on Zacks.com click here.</a>

Markets

Analyst Ratings

Should Maximus Stock be in Your Portfolio Pre-Q3 Earnings?

Maximus's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) short percent of float has fallen 37.36% since its last report. The company recently reported that it has 551 thousand shares sold short, which is 1.66% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.67 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Maximus Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722359710_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Maximus has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Maximus's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Maximus's peer group average for short interest as a percentage of float is 5.18%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into Maximus's Recent Short Interest

Maximus Awarded $87M Task Order By The IRS For Enterprise Development, Operations Service

Maximus's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) short percent of float has risen 59.86% since its last report. The company recently reported that it has 781 thousand shares sold short, which is 2.35% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.16 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Maximus Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1718283629_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Maximus has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Maximus's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Maximus's peer group average for short interest as a percentage of float is 4.92%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Buybacks

Maximus Announces Board Approval To Expand Stock Purchase Program Up To $200M, Including Approximately $6M Remaining From Existing Program

Bull of the Day: Maximus

Maximus Sees FY24 Revenue $5.15B-$5.25B Vs $4.29B Estimate

Maximus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) reported quarterly earnings of $1.57 per share which beat the analyst consensus estimate of $1.02 by 53.92 percent. This is a 93.83 percent increase over earnings of $0.81 per share from the same period last year. The company reported quarterly sales of $1.348 billion which beat the analyst consensus estimate of $1.280 billion by 5.32 percent. This is a 11.70 percent increase over sales of $1.207 billion the same period last year.

Maximus Q2 2024 Adj EPS $1.57 Beats $1.02 Estimate, Sales $1.348B Beat $1.280B Estimate

Maximus, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) is expected to release earnings results for its second quarter, after the <a href="https://www.benzinga.com/quote/MMS/earnings">closing bell on Wednesday.</a>
Analysts expect the McLean, Virginia-based company to report quarterly earnings at $1.02 per share, up from 52 cents per share in the year-ago period. Maximus is projected to post quarterly revenue of $1.28 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On April 5, Maximus announced a quarterly cash dividend of 30 cents per share, payable on May 31, 2024.
With the recent buzz around Maximus, some investors may be eyeing potential gains from the company's dividends. As of now, Maximus has a dividend yield of 1.42%, which is a quarterly dividend amount of 30 cents a share ($1.20 a year).
To figure out how to earn $500 monthly from Maximus, we start with the yearly target of $6,000 ($500 x 12 months).
Next, we take this amount and divide it by Maximus $1.20 dividend: $6,000 / $1.20 &nbsp;= 5,000 shares
So, an investor would need to own approximately $421,250 worth of Maximus, or 5,000 shares to generate a monthly dividend income of $500.
Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $1.20 = 1,000 shares, or $84,250 to generate a monthly dividend income of $100.
Also Read: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38668198/sabre-and-2-other-stocks-under-3-insiders-are-buying">Sabre And 2 Other Stocks Under $3 Insiders Are Buying</a>
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.
For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).
Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).
Further, the dividend payment itself can also change over time, which can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.
MMS Price Action: Shares of Maximus rose 0.2% to close at $84.25 on Tuesday.
Read More: <a href="https://www.benzinga.com/news/24/05/38667879/jim-cramer-calls-nutanix-the-perfect-enterprise-software-company-for-the-moment">Jim Cramer Calls Nutanix &#8216;The Perfect Enterprise Software Company For The Moment</a>&#8216;
Photo: Shutterstock

Long Ideas

Dividends

How To Earn $500 A Month From Maximus Stock Ahead Of Q2 Earnings

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fmaximus.com&amp;esheet=53895077&amp;newsitemid=20240212310999&amp;lan=en-US&amp;anchor=Maximus&amp;index=1&amp;md5=7dabde57aa482cf68fd5c39fa166bf47">Maximus</a>, a leading employer and provider of government services worldwide, today announced it has been selected by the state of South Dakota's Department of Social Services (DSS) to administer mental health assessments of individuals prior to placement in Medicaid-certified nursing facilities. The contract with Maximus marks a shift for the state, which had not previously worked with an outside vendor, to help advance the process for residents and bolster the overall program.
The assessment process, known as Preadmission Screening and Resident Review (PASRR), is conducted to ensure individuals receive the recommended services for their identified areas of need. Maximus has nearly 25 years of experience running <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fmaximus.com%2Fcapability%2Fpre-admission-screening-and-resident-review-pasrr&amp;esheet=53895077&amp;newsitemid=20240212310999&amp;lan=en-US&amp;anchor=high-quality%2C+person-centered+PASRR+programs&amp;index=2&amp;md5=a0e95bf6fe148c6ad64500fc5520031f">high-quality, person-centered PASRR programs</a> across a dozen states and will leverage that knowledge to support improvements across South Dakota's program and successfully deliver accurate, timely, and thorough assessments and clinical determinations.
"At Maximus, our mission is to move people forward, and the PASRR program is a perfect example of how we use our skills, experience, and talent to deliver better outcomes for all our state partners and to make a difference in the lives of the people we serve," said Christa Ballew, Senior Managing Director for Clinical Services, Maximus. "In South Dakota, our work will bring more centralization to the PASRR program and offer enhanced data collection and analysis to support the state's goals."
With Maximus as a partner, DSS will have a local solution for their PASRR program enhanced with national expertise. The company will utilize its industry leading PASRR methodology and clinical expertise, as well as a commitment to partner with the state to build an approach tailored to South Dakota's unique needs.

Maximus Awarded Mental Health Assessments Contract From South Dakota's Department Of Social Services

Maximus Maintains FY24 Revenue Guidance At $5.05B-$5.20B (Est. $5.14B), Boosts Adjusted EPS From $5.05-$5.35 To $5.20-$5.50 (Est. $4.24)

Maximus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) reported its Q1 earnings results on Wednesday, February 7, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Maximus beat estimated earnings by 32.67%, reporting an EPS of $1.34 versus an estimate of $1.01.
Revenue was up $78.00 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.26 which was followed by a 4.98% increase in the share price the next day.
Here's a look at Maximus's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.03</td>
<td>0.63</td>
<td>0.68</td>
<td>0.76</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.29</td>
<td>0.78</td>
<td>0.80</td>
<td>0.94</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.27B</td>
<td>1.20B</td>
<td>1.20B</td>
<td>1.15B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.26B</td>
<td>1.19B</td>
<td>1.21B</td>
<td>1.25B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Maximus management provided guidance for FY 2024, expecting earnings between $5.2 and $5.5 per share.
To track all earnings releases for Maximus <a href="https://www.benzinga.com/quote/MMS/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Maximus Q1 Earnings

Maximus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>) reported quarterly earnings of $1.34 per share which beat the analyst consensus estimate of $1.01 by 32.67 percent. The company reported quarterly sales of $1.33 billion which beat the analyst consensus estimate of $1.29 billion by 3.06 percent. This is a 6.24 percent increase over sales of $1.25 billion the same period last year.

Maximus Q1 2024 Adj EPS $1.34 Beats $1.01 Estimate, Sales $1.33B Beat $1.29B Estimate

ACLS

ADNT

ALCO

APPS

ARCC

ASGN

ASND

AVXL

AZTA

BABA

BARK

BERY

BLBD

CDAY

CENT

CENTA

CFLT

CMRE

COTY

CRTO

CSGS

EEFT

ENTA

EQNR

FLNC

FLNG

FORM

FOXA

GEOS

GPRE

GPRO

HAIN

INTR

MCFT

MKSI

MPWR

MSGE

MTRX

NBIX

NOTV

NTGR

NVST

NWSA

OESX

ORLY

OSCR

PAHC

Earnings Scheduled For February 7, 2024

Maximus awarded $87M task order by IRS

Maximus declares $0.30 dividend

MAXIMUS beats Q3 estimates, raises FY guidance

Maximus, Inc. 2024 Q3 - Results - Earnings Call Presentation

Maximus, Inc. (MMS) Q3 2024 Earnings Call Transcript

Maximus: An Undervalued Gem That Can Provide Double-Digit Returns

MAXIMUS declares $0.30 dividend

Maximus (MMS) announced they have filed suit in the U.S. Court of Federal Claims challenging the "baseless and unlawful" rebid of the U.S. Departme...

Maximus sues to challenge early rebid of 1-800-MEDICARE contract

Maximus files lawsuit against feds for rebid of Medicare contract

Defense, government contractor stocks shot down on sudden worries over Trump Pentagon

AMTM

CACI

DFEN

FITE

LDOS

SAIC

Press Releases

Maximus Schedules Fiscal 2024 Third Quarter Conference Call

Maximus Declares Quarterly Cash Dividend of $0.30 per Share

Maximus Reports Fiscal Year 2024 Third Quarter Results

Maximus Awarded OPM Contract for New Postal Service Health Benefits Program

Maximus Awarded $263 Million Contract from Pennsylvania's Department of Human Services to Provide Independent Enrollment Broker Services

Maximus Awarded $40 Million Task Order Under IRS Transformational Enterprise Development, Operations Service (EDOS) Contract

Maximus Schedules Fiscal 2024 Fourth Quarter and Year End Conference Call

Maximus Named to $300 Million IRS Consulting Services Blanket Purchase Agreement

Maximus Challenges Early Rebid of 1-800-MEDICARE Contract to U.S. Court of Federal Claims

Comments

Maximus

Vendite allo scoperto

Maximus (NYSE:MMS) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO